论文部分内容阅读
来自于欧洲和美国的研究人员报道说,罗苏伐他汀(rosuvastatin,RV)在降低LDL(低密度脂蛋白)胆固醇方面似乎比阿伐他汀(atorvastatin,AV)有更好的成本效益。英国AstraZeneca有限公司的Mark Hirsch博士
Researchers from Europe and the United States reported that rosuvastatin (RV) appears to be more cost-effective than atorvastatin (AV) in lowering LDL (low density lipoprotein) cholesterol. Dr. Mark Hirsch, AstraZeneca Ltd, UK